Delivery Order SPE2DB25D3020-SPE2DB25FWJRL
- Not listed
- The Defense Logistics Agency awarded a $10,393.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for XOLAIR 300 mg/2 mL syringes on July 9, 2025, with completion targeted for July 30, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $21,610.20 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes on August 13, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract fulfilling pharmaceutical supply requirements for federal medical procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of XOLAIR 150 mg/ml syringes, with a contract ceiling value of $5,762.72 and an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XOLAIR 300 mg/2 mL syringes with a ceiling value of $1,732.19. This competitively awarded, non-set-aside contract was issued on July 22, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, under firm fixed pricing terms. This delivery order is issued against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of XOLAIR 150 mg/ml syringes, with a contract ceiling value of $2,161.02 and a completion date of June 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $2,881.36 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/ml syringe. The contract is a firm fixed price delivery order with an ultimate completion date of June 17, 2025, and represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xolair 75 mg/0.5 ml syringes with a ceiling value of $1,080.54 and a firm fixed price structure. This delivery order is non-set-aside and represents a competitively awarded contract with an ultimate completion date of August 11, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $6,928.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XOLAIR 300 mg/2 ml syringes. The contract, which is classified as a non-set-aside competitive award, is scheduled for completion by August 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,322.04 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is for performance at AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,161.02 to AmerisourceBergen Drug Corp for the supply of XOLAIR 150 mg/ml syringes. The award was made on July 24, 2025, with an ultimate completion date of August 14, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor specializing in...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJRLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XOLAIR 300 mg/2 mL syringes with a ceiling value of $1,732.19. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with an ultimate completion date of August 13, 2025. The delivery order is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This contract represents a child order under a larger indefinite delivery contract vehicle, demonstrating the vendor's role as a pharmaceutical supplier to federal military healthcare systems. This delivery order is issued under AmerisourceBergen's prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications, medical devices, and healthcare commodities to support military healthcare programs worldwide. XOLAIR, a specialty pharmaceutical product, aligns with AmerisourceBergen's extensive portfolio of brand-name and generic medications delivered through the Defense Logistics Agency's medical supply chain to support Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/23/25 |